Rachana Singh1,2, Rachel Rothstein3,4, Karen Ricci3, Paul Visintainer5,6, Jeffrey Shenberger3,7, Eilean Attwood3,5, Peter Friedmann3,6. 1. Baystate Medical Center, Springfield, MA, USA. drrachanasingh@gmail.com. 2. University of Massachusetts Medical School-Baystate, Springfield, MA, USA. drrachanasingh@gmail.com. 3. Baystate Medical Center, Springfield, MA, USA. 4. Penn State College of Medicine, Hershey, PA, USA. 5. University of Massachusetts Medical School-Baystate, Springfield, MA, USA. 6. Office of Research, UMMS-Baystate, Springfield, MA, USA. 7. Wake Forest School of Medicine, Winston-Salem, NC, USA.
Abstract
OBJECTIVE: Assess impact of parental involvement in care provision for term substance exposed newborns (SENs). STUDY DESIGN: Prospective observational cohort study included mothers with opioid use disorder and their SENs over 4 year study period. Maternal-Infant dyads enrolled in EMPOWER and rooming-in (RI) programs were included and received care 24/7 in a private room until newborn's discharge. Outcomes were compared for dyads participating in EMPOWER/RI with historical controls. RESULTS: Ninety of 156 historical SENs were RI eligible, while 49 of 108 SENs born during RI period had mothers enrolled in EMPOWER. EMPOWER/RI SENs had lower rates for and duration of pharmacotherapy, shorter neonatal intensive care unit (NICU) and hospital lengths of stay. EMPOWER/RI increased initiation and continuation of breastfeeding at discharge. CONCLUSIONS: Parental participation was associated with a decrease in initiation and duration of pharmacotherapy, NICU admission, length of stay and hospital charges while increasing breastfeeding initiation and continuation at discharge.
OBJECTIVE: Assess impact of parental involvement in care provision for term substance exposed newborns (SENs). STUDY DESIGN: Prospective observational cohort study included mothers with opioid use disorder and their SENs over 4 year study period. Maternal-Infant dyads enrolled in EMPOWER and rooming-in (RI) programs were included and received care 24/7 in a private room until newborn's discharge. Outcomes were compared for dyads participating in EMPOWER/RI with historical controls. RESULTS: Ninety of 156 historical SENs were RI eligible, while 49 of 108 SENs born during RI period had mothers enrolled in EMPOWER. EMPOWER/RI SENs had lower rates for and duration of pharmacotherapy, shorter neonatal intensive care unit (NICU) and hospital lengths of stay. EMPOWER/RI increased initiation and continuation of breastfeeding at discharge. CONCLUSIONS: Parental participation was associated with a decrease in initiation and duration of pharmacotherapy, NICU admission, length of stay and hospital charges while increasing breastfeeding initiation and continuation at discharge.